Regulatory Guidance Review - April 2019
Latest Updates from FDA & EMA
April 2019 Updates
Each month, Veristat's regulatory team tracks and...
Posts about
Regulatory Submissions (14)
Regulatory Guidance Review
Latest Updates from FDA & EMA
March 2019
Each month, Veristat's regulatory team tracks and shares...
Is Your Complex NDA/MAA Submission Missing One of These Key Elements?
Veristat has experience in preparing more than 120 marketing applications. Our exposure to in...
Key Strategies for Overcoming Data Analysis Difficulties During NDA/MAA Submissions
When database locks are delayed, or regulatory agencies request additional analyses for new drug...
Streamline the Medical Writing Process for Simultaneous Submissions
When a team faces multiple submissions in a short timeframe or even simultaneous submissions,...
Top 10 Operational Tips for Navigating Complex NDA/MAA Submissions
No two New Drug Applications (NDAs) or Marketing Authorization Applications (MAAs) are the same....